Neil P. Robertson

Heath Park
Cardiff, WLS, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

Journal: Health technology assessment (Winchester, England)

Published: June 29, 2026

Genetic subtypes of multiple sclerosis severity are uncoupled from inflammatory lesion burden.

Genetic subtypes of multiple sclerosis severity are uncoupled from inflammatory lesion burden.

Journal: Acta neuropathologica

Published: June 16, 2026

Adherence to risk minimization measures for alemtuzumab use in multiple sclerosis: a drug utilization study in four European countries.

Adherence to risk minimization measures for alemtuzumab use in multiple sclerosis: a drug utilization study in four European countries.

Journal: Therapeutic advances in neurological disorders

Published: November 11, 2025

MOGAD in South Wales: Diagnostic Evolution and Disease Epidemiology.

MOGAD in South Wales: Diagnostic Evolution and Disease Epidemiology.

Journal: European journal of neurology

Published: October 14, 2025

Clinical commentary to "Alemtuzumab: balancing risks".

Clinical commentary to "Alemtuzumab: balancing risks".

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: August 20, 2025

Genetic subtypes associated with multiple sclerosis severity and response to treatment.

Genetic subtypes associated with multiple sclerosis severity and response to treatment.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: August 05, 2025

Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.

Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.

Journal: Lancet (London, England)

Published: March 23, 2025

Real-world observational study of infections in people treated with ocrelizumab for multiple sclerosis.

Real-world observational study of infections in people treated with ocrelizumab for multiple sclerosis.

Journal: Journal of neurology

Published: December 11, 2024

Multiple Sclerosis and Seizures: Clinical, Diagnostic and Therapeutic Correlations.

Multiple Sclerosis and Seizures: Clinical, Diagnostic and Therapeutic Correlations.

Journal: Brain and behavior

Published: October 25, 2024

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.

Journal: BMJ open

Published: September 16, 2024

Sterol imbalances and cholesterol-24-hydroxylase dysregulation is linked to the underlying progression of multiple sclerosis.

Sterol imbalances and cholesterol-24-hydroxylase dysregulation is linked to the underlying progression of multiple sclerosis.

Journal: Brain pathology (Zurich, Switzerland)

Published: September 02, 2024

Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis.

Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: August 01, 2024

Showing 1-12 of 52

Last Updated: 09/26/2026